Cardiogeni Plc
A clinical-stage biotech developing regenerative medicines for heart failure.
Aquis Stock Exchange
Overview
Corporate Details
- ISIN(s):
- GB00BTBLFC12
- LEI:
- 9845000F8F59ATZD8F92
- Country:
- United Kingdom
- Address:
- Celixir House Stratford-Upon-Avon Business & Technology Park, CV37 7GZ Stratford-Upon-Avon
- Website:
- https://cardiogeni.com/
- Sector:
- Manufacturing
Description
Cardiogeni Plc is a clinical-stage biotechnology company specializing in the development of regenerative medicines for the treatment of heart failure. Founded by Nobel Laureate Sir Martin Evans, the company focuses on creating novel therapies to address life-threatening cardiovascular diseases. Cardiogeni aims to become a market leader in heart failure regeneration by advancing its product pipeline, which includes candidates like heartcel, through clinical development and commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-31 13:35 |
Result of Annual General Meeting
|
English | HTML • 12.5 KB | ||
| 2025-12-29 08:20 |
Interim Results
|
English | HTML • 126.7 KB | ||
| 2025-12-08 16:10 |
Notice of Annual General Meeting
|
English | HTML • 13.6 KB | ||
| 2025-10-24 08:00 |
Restatement of Financial Statements
|
English | HTML • 35.1 KB | ||
| 2025-09-30 18:51 |
Annual Results to 31 March 2025
|
English | HTML • 129.7 KB | ||
| 2025-08-29 18:37 |
Director's Dealings
|
English | HTML • 22.7 KB | ||
| 2025-08-29 11:55 |
Board Appointment of (Lord) James Nicholas Bethell
|
English | HTML • 19.5 KB | ||
| 2025-07-24 17:45 |
Details of Advanced Subscription & Company Update
|
English | HTML • 21.0 KB | ||
| 2025-07-24 08:00 |
£150,000 Advanced Subscription Agreement
|
English | HTML • 14.2 KB | ||
| 2025-07-02 08:00 |
Appointment of corporate broker
|
English | HTML • 11.6 KB | ||
| 2025-06-05 13:40 |
Formation of UAE joint venture company
|
English | HTML • 15.9 KB | ||
| 2025-06-03 17:23 |
TR-1: Notification of major holdings
|
English | HTML • 50.7 KB | ||
| 2025-05-22 08:00 |
£650,000 Placing at 17.3p per share
|
English | HTML • 18.4 KB | ||
| 2025-04-01 08:00 |
Update on JV including £20m Funding
|
English | HTML • 13.6 KB | ||
| 2025-02-28 08:00 |
Director’s Dealings
|
English | HTML • 24.8 KB |
Automate Your Workflow. Get a real-time feed of all Cardiogeni Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cardiogeni Plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cardiogeni Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
